Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MISTY SHARP INGRAM

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1437774080
CMS profile
10459071
Location
COLLINSVILLE, AL

General Payments · PY2023–2024

$333.87

  • Reported across 16 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$320.08

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $320.08 15

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $52.30 3
Otsuka America Pharmaceutical, Inc. $47.37 2
GlaxoSmithKline, LLC. $42.78 2
Exact Sciences Corporation $42.69 2
Astellas Pharma US Inc $32.29 1
Novo Nordisk AS $25.18 1
ABBVIE INC. $21.76 1
DEXCOM, INC. $20.87 1
Lilly USA, LLC $18.88 1
ITI, Inc. $15.96 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2023 $13.79 1
PY2024 $320.08 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $21.76 08/08/2024 Food and Beverage Undisputed 01/23/2026 1107383122 CMS
Astellas Pharma US Inc $32.29 01/12/2024 Food and Beverage Undisputed 01/23/2026 1139474054 CMS
AstraZeneca Pharmaceuticals LP $17.04 05/13/2024 Food and Beverage Undisputed 01/23/2026 1104225429 CMS
AstraZeneca Pharmaceuticals LP $15.24 10/28/2024 Food and Beverage Undisputed 01/23/2026 1105898900 CMS
AstraZeneca Pharmaceuticals LP $20.02 11/07/2024 Food and Beverage Undisputed 01/23/2026 1104721149 CMS
Dexcom, Inc. $20.87 04/29/2024 Food and Beverage Undisputed 01/23/2026 1153380194 CMS
Exact Sciences Corporation $21.59 05/02/2024 Food and Beverage Undisputed 01/23/2026 1114557607 CMS
Exact Sciences Corporation $21.10 09/30/2024 Food and Beverage Undisputed 01/23/2026 1114557611 CMS
GlaxoSmithKline, LLC. $19.86 10/15/2024 Food and Beverage Undisputed 01/23/2026 1115980650 CMS
GlaxoSmithKline, LLC. $22.92 12/03/2024 Food and Beverage Undisputed 01/23/2026 1116457631 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $15.96 11/12/2024 Food and Beverage Undisputed 01/23/2026 1143511241 CMS
Lilly USA, LLC $18.88 08/29/2024 Food and Beverage Undisputed 01/23/2026 1135848284 CMS
Novo Nordisk Inc $25.18 10/23/2024 Food and Beverage Undisputed 01/23/2026 1100603260 CMS
Otsuka America Pharmaceutical, Inc. $18.60 01/23/2024 Food and Beverage Undisputed 01/23/2026 1119101718 CMS
Otsuka America Pharmaceutical, Inc. $28.77 10/02/2024 Food and Beverage Undisputed 01/23/2026 1119101720 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2023, 2024
Source files
Dataset page · Bulk file · PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.